Abstract
The mechanisms underlying the chronic hepatic inflammatory process in hepatitis C virus (HCV) infection are not well understood. Some models of experimentally induced hepatitis point to a role of interferon-gamma (IFN-γ) secreted by liver-infiltrating peripheral blood lymphocytes (PBMC) in mediating hepatocellular injury. In the present study, IFN-γ gene expression was analysed in PBMC and in liver biopsy specimens from patients with chronic HCV infection using a quantitative reverse transcriptase polymerase chain reaction technique. IFN-γ gene expression by PBMC from HCV-infected patients exhibiting elevated serum transaminase activities was found to be increased up to ninefold when compared with (1) healthy individuals, (2) HCV-infected patients exhibiting normal or only slightly elevated serum enzyme activities, or (3) patients with drug-induced elevated serum transaminase activity. A histo-pathological evaluation of liver biopsy sections revealed further that high IFN-γ gene expression by PBMC was associated with a more pronounced degree of inflammatory activity. In individual patients, the expression of IFN-γ by PBMC was shown to parallel closely serum transaminase activities during IFN-α 2a therapy. Moreover, liver biopsy material from patients chronically infected with HCV contained higher amounts of IFN-γ transcripts than liver tissue from patients with liver disorders unrelated to HCV infection or without any liver disease. These data thus demonstrate a close association between the amount of IFN-γ transcripts in PBMC and in liver tissue and the inflammatory activity in chronic HCV infection in man.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 9 March 1996
Rights and permissions
About this article
Cite this article
Mihm, S., Hutschenreiter, A., Fayyazi, A. et al. High inflammatory activity is associated with an increased amount of IFN-γ transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection. Med Microbol Immunol 185, 95–102 (1996). https://doi.org/10.1007/s004300050020
Issue Date:
DOI: https://doi.org/10.1007/s004300050020